Cell Receptor

Cell Receptor Inc. develops a future-oriented therapy for high medical needs: cancer and autoimmune diseases

Cell Receptor is a small Geneva based startup company, aiming to establish a new option in the treatment of cancer and autoimmune diseases: The Cell Receptor team has since 2010 been actively engaged in research on cell proliferation and possesses unique knowledge of a very basic control mechanism of cell growth in our body, that was previously unknown and therefore has not been the subject of therapeutic efforts. Cell Receptor has also knowledge of groups of pharmacological substances able to interfere with this mechanism, and has, basing thereupon, developed a new method for the prevention of cancer metastases. The treatment has the potential to inhibit cancer metastasis at very reasonable costs. Therefore, it is expected that the clinical demand and thus the expected sales will be quite substantial. Cell Receptor will fund a clinical trial as a proof of its concept and is expanding its activities for this purpose.